| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Elevance Health, Inc.$375.84
-0.56 (-0.15%)
F 17Pipeline Score Tools & Services · Commercial
Market Cap
68.76 B
EPS
25.18
P/E Ratio
12.41 $
Value Trade
581.94 M
SEC Financials
Q2 2026Dilution Risk
Revenue
50.47 B
Total Assets
126.44 B
Total Liabilities
81.42 B
Equity
44.88 B
D/E Ratio
12,345
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
35.95 B
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
Jul 15, 2026
Overview
Volume
977.24 K
52 Week Range
273.71 - 443.29
% held by Insiders
0.3 %
% held by Institutions
93.21 %
Enterprise Value
101.61 B
Total Shares
217.18 M
Short %
2.78 %
Float Shares
216.97 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
F17
Pipeline Score -
Pipeline ValueValuation Signal
0
Drugs Scored—
rNPV / MCap Top 16%
Large Pharma (rank 768 of 913)
Percentile RankElevance Health, Inc. has significant pipeline risk (17/100).
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in ELV
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
ELV Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-10-16 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-10-16 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-10-16 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-ELV
Jul 30, 2026▼ -0.1%today
Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
Elevance Health is enhancing its connected cancer care model to provide better support for consumers throughout their health journeys. The initiative focuses on earlier support, personalized care navigation, and improved coordination of care. This enhancement aims to address the emotional and logistical challenges faced by cancer patients.
Read more →-ELV
Jul 15, 2026▼ -8.5%on this news
Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
Elevance Health, Inc. reported strong second quarter 2026 results that surpassed expectations, driven by effective execution and enhanced operational performance. The company has raised its full-year adjusted EPS guidance to a minimum of $27.00. This positive outlook reflects their commitment to investing in key areas such as medical cost management and member experience.
Read more →-ELV
Jul 6, 2026Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
Elevance Health has announced a conference call and webcast scheduled for July 15, 2026, to discuss its second quarter results for the year. This event aims to provide insights into the company's financial performance during that period. Further details regarding the call's agenda and participation will likely be shared closer to the date.
Read more →-ELV
Jun 29, 2026Elevance Health Foundation Invests $5.8 Million to Strengthen Behavioral Health Access Nationwide
Elevance Health Foundation has announced a $5.8 million investment aimed at improving access to behavioral health services across the United States. This initiative is designed to strengthen mental health support systems, reflecting the foundation's commitment to addressing behavioral health challenges. The funding will facilitate broader access to essential services nationwide.
Read more →-ELV
Jun 25, 2026New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
The article discusses a study conducted by Elevance Health's Public Policy Institute regarding payment disputes for planned procedures under the No Surprises Act. However, the content is limited and does not provide detailed findings or implications of the study. Further information is needed to understand the study's conclusions and its impact on healthcare policy.
Read more →-ELV
Jun 24, 2026Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation
Thomas Carr Howe Middle School has launched a new fitness and strength training space through a partnership with Elevance Health and the Impact Fitness Foundation. This initiative aims to promote health and wellness among students. The collaboration reflects a commitment to enhancing physical education resources in schools.
Read more →-ELV
Jun 23, 2026Elevance Health Makes Clinical Review Faster, More Connected with Health OS
Elevance Health has introduced a new Health OS aimed at enhancing the clinical review process. This system is designed to make the review process faster and more interconnected. However, specific details about the features and benefits of Health OS are not provided in the article.
Read more →-ELV
Jun 17, 2026Elevance Health Announces $640 Million Investment in Affordable Housing Over the Past Five Years, Surpassing $1 Billion in Total Commitment Nationwide
Elevance Health has announced that it has invested $640 million in affordable housing over the past five years. This investment contributes to a total commitment of over $1 billion nationwide. The company aims to address housing challenges and improve community health outcomes through these efforts.
Read more →-ELV
Jun 15, 2026Elevance Health Makes Chronic Care Easier to Navigate With Connected, Personalized Support
Elevance Health has introduced a new initiative aimed at simplifying chronic care management. The program focuses on providing connected and personalized support to patients, enhancing their navigation through the healthcare system. This move is expected to improve patient experiences and outcomes in managing chronic conditions.
Read more →-ELV
Apr 22, 2026Elevance Health Reports First Quarter 2026 Results; Raises Full-Year Guidance
Elevance Health reported strong first quarter 2026 results, surpassing expectations and raising its full-year adjusted EPS guidance. The company experienced growth in operating revenue, primarily driven by higher premium yields. However, it also noted a decrease in operating gain and anticipated declines in certain membership segments, reflecting challenges in the Medicaid and Medicare Advantage areas.
Read more →-ELV
Oct 21, 2025E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS THIRD QUARTER 2025 RESULTS Executing with discipline to improve affordability and elevate the member experience 3Q 2025 operating revenue of $50.1 billion, up 12.0% f
Elevance Health, Inc. reported a 12% increase in third quarter operating revenue for 2025, reaching $50.1 billion, largely due to higher premium yields and growth in Medicare Advantage membership. Despite the revenue growth, operating gain and margins decreased, attributed to increased medical costs and ongoing Medicaid membership losses. The company's strategic focus remains on improving affordability and member experience, and it is actively investing in technology and workforce capabilities. Shareholder returns included a quarterly dividend and significant share repurchase activity.
Read more →-ELV
Apr 18, 2024EARNINGS RELEASE ELEVANCE HEALTH REPORTS FIRST QUARTER 2024 RESULTS 1Q 2024 operating revenue of $42.3 billion, up 0.9% from 1Q 2023 1Q 2024 diluted EPS 1 of $9.59, up 15.5% from 1Q 2023 and adjusted diluted EPS 2 of $10
Elevance Health (NYSE: ELV) reported its first-quarter results for 2024, showing an operating revenue of $42.3 billion, a modest increase compared to the same period last year. The company's diluted EPS increased significantly by 15.5% to $9.59. Despite challenges such as Medicaid membership attrition, Elevance is optimistic about expanding its Carelon services and has raised its full-year earnings outlook. Additionally, the company has established a partnership aimed at enhancing value-based care and healthcare delivery innovation.
Read more →-ELV
Jan 24, 2024E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS RESULTS FOR FOURTH QUARTER AND FULL YEAR 2023; SETS FULL YEAR 2024 OUTLOOK 4Q 2023 operating revenue of $42.5 billion, up 7.0% from 4Q 2022; FY 2023 operating revenue
Elevance Health has released its earnings report for Q4 2023 and the full year, revealing strong performance with a 7% rise in operating revenue to $42.5 billion. The growth was attributed to higher premium and pharmacy product revenues. However, the company faced a decline in medical membership and a slight decrease in operating gain for the fourth quarter. The outlook for 2024 remains optimistic as Elevance continues to focus on innovation and customer experience.
Read more →-ELV
Oct 18, 2023ELEVANCE HEALTH REPORTS THIRD QUARTER 2023 RESULTS Third quarter GAAP net income was $5.45 per share, including net negative adjustment items of $3.54 per share. Adjusted net income was $8.99* per share. Operating gain,
Elevance Health, Inc. reported strong financial performance for the third quarter of 2023, highlighting a GAAP net income of $5.45 per share and an adjusted net income of $8.99 per share. However, the company experienced a drop in medical membership, with a decrease of 664,000 members attributed mainly to Medicaid attrition. Despite this, overall operating revenue grew by 7.2%, driven by higher premium revenues and the acquisition of BioPlus. The company also announced plans to enhance operational efficiency after a strategic review, which led to certain optimization charges.
Read more →-ELV
Aug 8, 2023Elevance Health Announces John Gallina to Retire as CFO Mark Kaye named Executive Vice President, Chief Financial Officer INDIANAPOLIS
Elevance Health has announced the retirement of John Gallina as CFO, effective later this year. Mark Kaye has been appointed as the new executive vice president and CFO, bringing significant financial experience from Moody's Corporation. Gallina will continue to support the company as a Special Advisor during the transition to ensure a seamless changeover in leadership. Elevance Health aims to sustain its commitment to improving community health through this transition.
Read more →-ELV
Jul 19, 2023P R E S S R E L E A S E ELEVANCE HEALTH REPORTS SECOND QUARTER 2023 RESULTS Second quarter GAAP net income was $7.79 per share, including net negative adjustment items of $1.25 per share. Adjusted net income was $9.04* p
Elevance Health, Inc. reported strong second-quarter results for 2023, showcasing double-digit growth in revenue and significant adjusted earnings. The company anticipates higher GAAP net income expectations for the year, bolstered by growing membership across key segments like Medicaid and Medicare. Despite a decrease in medical membership tied to eligibility redeterminations, the overall performance indicates a successful execution of strategic initiatives. The company's focus on optimizing existing businesses and investing in growth areas positions it positively for the remainder of 2023.
Read more →-ELV
Apr 19, 2023▼ -5.3%on this news
ELEVANCE HEALTH REPORTS FIRST QUARTER 2023 RESULTS First quarter GAAP net income was $8.30 per share, including net negative adjustment items of $1.16 per share. Adjusted net income was $9.46* per share. Operating revenu
Elevance Health, Inc. reported strong first quarter results for 2023, achieving a GAAP net income of $8.30 per share and an adjusted net income of $9.46 per share. The company's operating revenue rose by 10.6% to $41.9 billion, driven by growth in Medicaid, Medicare Advantage, and pharmacy products. Medical membership increased by approximately 1.3 million compared to the previous year, reflecting a robust demand for their services. Elevated expectations for future GAAP and adjusted net income indicate bullish market confidence.
Read more →-ELV
Jan 25, 2023ELEVANCE HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS Fourth quarter and full year GAAP net income was $3.93 and $24.81 per share Fourth quarter and full year adjusted net income was $5.23* and
Elevance Health, Inc. reported robust financial results for the fourth quarter and full year 2022, showcasing significant growth in revenue and adjusted net income. The company experienced strong increases in membership, particularly within its Medicaid and Medicare Advantage sectors. While it anticipates continued growth, challenges in operating cash flow and investment portfolio losses may pose risks to its financial stability. Elevance Health also announced an increased dividend and an expansion of its share repurchase program.
Read more →-ELV
Oct 25, 2022Elevance Health Board Welcomes Deanna Strable as New Director INDIANAPOLIS
Elevance Health Board Welcomes Deanna Strable as New Director INDIANAPOLIS October 25, 2022 The Board of Directors of Elevance Health (NYSE: ELV) announced that Deanna Strable will be joining the Board. She will serve on the Audit and Governance Committees. With a career spanni
Read more →-ELV
Oct 19, 2022ELEVANCE HEALTH REPORTS THIRD QUARTER 2022 RESULTS, RAISES FULL YEAR OUTLOOK Third quarter GAAP net income was $6.68 per share, including net negative adjustment items of $0.85 per share. Adjusted net incom
ELEVANCE HEALTH REPORTS THIRD QUARTER 2022 RESULTS, RAISES FULL YEAR OUTLOOK Indianapolis, Ind. - October 19, 2022 - Elevance Health, Inc. (NYSE: ELV) reported third quarter 2022 results reflecting strong financial performance, including double-digit growth in revenue, operatin
Read more →-ELV
Jul 20, 2022▼ -7.6%on this news
ELEVANCE HEALTH REPORTS SECOND QUARTER 2022 RESULTS, RAISES FULL YEAR OUTLOOK Second quarter GAAP net income was $6.79 per share, including net negative adjustment items of $1.25 per share. Adjusted net income was $8.04*
ELEVANCE HEALTH REPORTS SECOND QUARTER 2022 RESULTS, RAISES FULL YEAR OUTLOOK Indianapolis, Ind. July 20, 2022 Elevance Health, Inc. (NYSE: ELV) reported second quarter 2022 results reflecting strong financial performance, including double-digit growth in revenue, operating ear
Read more →-ELV
Apr 20, 2022ANTHEM REPORTS FIRST QUARTER 2022 RESULTS, REFLECTING STRONG MOMENTUM ACROSS ALL DIVISIONS First quarter GAAP net income was $7.39 per share, including net negative adjustment items of $0.86 per share. Adju
ANTHEM REPORTS FIRST QUARTER 2022 RESULTS, REFLECTING STRONG MOMENTUM ACROSS ALL DIVISIONS Indianapolis, Ind. - April 20, 2022 - Anthem, Inc. (NYSE: ANTM) reported first quarter 2022 results reflecting strong financial performance, including double-digit top and bottom line gro
Read more →-ELV
Jan 26, 2022ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2021 RESULTS Fourth quarter GAAP net income was $4.63 per share, including net negative adjustment items of $0.51 per share. Adjusted net income was $5.14* per share. Full year
ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2021 RESULTS Indianapolis, Ind. - January 26, 2022 - Anthem, Inc. (NYSE: ANTM) reported fourth quarter and full year 2021 results reflecting strong financial performance, including double-digit top and bottom line growth. 2021 was ano
Read more →-ELV
Oct 20, 2021ANTHEM REPORTS THIRD QUARTER 2021 RESULTS, RAISES FULL YEAR OUTLOOK Third quarter GAAP net income was $6.13 per share, including net negative adjustment items of $0.66 per share. Adjusted net income was $6.
ANTHEM REPORTS THIRD QUARTER 2021 RESULTS, RAISES FULL YEAR OUTLOOK Indianapolis, Ind. - October 20, 2021 Anthem, Inc. (NYSE: ANTM) reported third quarter 2021 results reflecting strong financial performance. Our deep connection to the communities we serve, commitment to advan
Read more →-ELV
Aug 4, 2021Anthem s Board Welcomes Susan Dodson DeVore as New Director INDIANAPOLIS
Anthem s Board Welcomes Susan Dodson DeVore as New Director INDIANAPOLIS August 4, 2021 The Board of Directors of Anthem, Inc. (NYSE: ANTM) announced that Susan Dodson DeVore has joined the Board. Ms. DeVore s decades of leadership in the healthcare and financial industries dem
Read more →-ELV
Jul 21, 2021ANTHEM REPORTS SECOND QUARTER 2021 RESULTS, RAISES FULL YEAR OUTLOOK Second quarter GAAP net income was $7.25 per share, including net positive adjustment items of $0.22 per share. Adjusted net income was $
ANTHEM REPORTS SECOND QUARTER 2021 RESULTS, RAISES FULL YEAR OUTLOOK Indianapolis, Ind. - July 21, 2021 - Anthem, Inc. (NYSE: ANTM) reported second quarter 2021 results reflecting strong financial performance. We continued to deliver on our commitments to our stakeholders whil
Read more →-ELV
Apr 21, 2021ANTHEM REPORTS FIRST QUARTER 2021 RESULTS, RAISES FULL YEAR OUTLOOK First quarter GAAP net income was $6.71 per share, including net negative adjustment items of $0.30 per share. Adjusted net income was $7.
ANTHEM REPORTS FIRST QUARTER 2021 RESULTS, RAISES FULL YEAR OUTLOOK Indianapolis, Ind. - April 21, 2021 - Anthem, Inc. (NYSE: ANTM) reported first quarter 2021 results that reflect strong financial performance. Our results in the first quarter reflect strong execution and a co
Read more →-ELV
Jan 27, 2021ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2020 RESULTS Indianapolis, Ind.
ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2020 RESULTS Indianapolis, Ind. January 27, 2021 Anthem, Inc. (NYSE: ANTM) reported fourth quarter 2020 results that reflected solid performance across the enterprise. Despite uncertainties with the pandemic, Anthem delivered strong g
Read more →-ELV
Oct 28, 2020ANTHEM REPORTS THIRD QUARTER RESULTS REAFFIRMS COMMITMENT TO STAKEHOLDERS DURING COVID-19 PANDEMIC Indianapolis, Ind.
ANTHEM REPORTS THIRD QUARTER RESULTS REAFFIRMS COMMITMENT TO STAKEHOLDERS DURING COVID-19 PANDEMIC Indianapolis, Ind. - October 28, 2020 - Anthem, Inc. (NYSE: ANTM) reported third quarter 2020 results that reflect the impacts of ongoing COVID-19 costs and the continued recover
Read more →-ELV
Jul 29, 2020ANTHEM REPORTS SECOND QUARTER RESULTS REAFFIRMS COMMITMENT TO STAKEHOLDERS DURING COVID-19 PANDEMIC Indianapolis, Ind.
ANTHEM REPORTS SECOND QUARTER RESULTS REAFFIRMS COMMITMENT TO STAKEHOLDERS DURING COVID-19 PANDEMIC Indianapolis, Ind. - July 29, 2020 - Against the backdrop of the ongoing pandemic, Anthem, Inc. (NYSE: ANTM) has continued to take bold steps to directly support its health plan
Read more →-ELV
Apr 29, 2020ANTHEM PROVIDES NATIONWIDE COORDINATED RESPONSE TO COVID-19 Indianapolis, Ind.
ANTHEM PROVIDES NATIONWIDE COORDINATED RESPONSE TO COVID-19 Indianapolis, Ind. - April 29, 2020 - Against the backdrop of the national healthcare crisis, Anthem, Inc. (NYSE: ANTM) has been deeply committed to supporting its health plan members, customers, care providers, associ
Read more →-ELV
Jan 29, 2020ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS REFLECTING SOLID PERFORMANCE Fourth quarter net income was $3.62 per share, including net negative adjustment items of $0.26 per share. Adjusted net
ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS REFLECTING SOLID PERFORMANCE Indianapolis, Ind. January 29, 2020 Anthem, Inc. (NYSE: ANTM) reported fourth quarter and full year financial 2019 results that reflect double-digit top and bottom line growth and the successf
Read more →-ELV
Oct 23, 2019ANTHEM REPORTS THIRD QUARTER 2019 RESULTS Third quarter net income was $4.55 per share, including net negative adjustment items of $0.32 per share. Adjusted net income was $4.87* per share. Operating revenu
ANTHEM REPORTS THIRD QUARTER 2019 RESULTS Indianapolis, Ind. October 23, 2019 Anthem, Inc. (NYSE: ANTM) today announced third quarter financial results driven by strong revenue growth and improved operational execution. Anthem s third quarter results showed continued membership
Read more →-ELV
Oct 1, 2019Anthem s Board Welcomes Ryan Schneider as New Director INDIANAPOLIS
Anthem s Board Welcomes Ryan Schneider as New Director INDIANAPOLIS October 1, 2019 The Board of Directors of Anthem, Inc. (NYSE: ANTM) announced that Ryan Schneider has joined the Board. With more than two decades of leadership experience in the financial sector, Mr. Schneider
Read more →-ELV
Jul 24, 2019ANTHEM REPORTS SECOND QUARTER 2019 RESULTS, RAISES FULL YEAR OUTLOOK Second quarter net income was $4.36 per share, including net negative adjustment items of $0.28 per share. Adjusted net income was $4.64*
ANTHEM REPORTS SECOND QUARTER 2019 RESULTS, RAISES FULL YEAR OUTLOOK Indianapolis, Ind. July 24, 2019 Anthem, Inc. (NYSE: ANTM) reported second quarter financial results driven by strong revenue growth and steady progress on the implementation of IngenioRx. Our second quarter
Read more →-ELV
Apr 24, 2019ANTHEM REPORTS FIRST QUARTER 2019 RESULTS, RAISES FULL YEAR OUTLOOK First quarter net income was $5.91 per share, including net negative adjustment items of $0.12 per share. Adjusted net income was $6.03* p
ANTHEM REPORTS FIRST QUARTER 2019 RESULTS, RAISES FULL YEAR OUTLOOK Indianapolis, Ind. April 24, 2019 Anthem, Inc. (NYSE: ANTM) reported first quarter financial results that were driven by solid membership growth across all lines of business. Our first quarter 2019 results rep
Read more →-ELV
Jan 30, 2019ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2018 RESULTS REFLECTING STRONG CORE PERFORMANCE Fourth quarter net income was $1.61 per share, including net negative adjustment items of $0.83 per share. Adjusted net income w
ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2018 RESULTS REFLECTING STRONG CORE PERFORMANCE Indianapolis, Ind. January 30, 2019 Anthem, Inc. (NYSE: ANTM) reported fourth quarter and full year 2018 financial results that reflected enhanced performance across the core businesses
Read more →-ELV
Oct 31, 2018ANTHEM REPORTS THIRD QUARTER 2018 RESULTS REFLECTING STRENGTHENING OPERATING PERFORMANCE Third quarter net income was $960 million, growth of 29% over the prior year quarter. Adjusted net income of $3.81 per share grew b
ANTHEM REPORTS THIRD QUARTER 2018 RESULTS REFLECTING STRENGTHENING OPERATING PERFORMANCE Indianapolis, Ind. October 31, 2018 Anthem, Inc. (NYSE: ANTM) announced third quarter 2018 financial results that reflect improving fundamental execution across the business. Our third qua
Read more →-ELV
Jul 25, 2018ANTHEM REPORTS SECOND QUARTER 2018 RESULTS REFLECTING STRONG OVERALL ENTERPRISE-WIDE EXECUTION Second quarter net income was $1.1 billion, growth of 23% over the prior year quarter. Adjusted net income of $4.25 per share
ANTHEM REPORTS SECOND QUARTER 2018 RESULTS REFLECTING STRONG OVERALL ENTERPRISE-WIDE EXECUTION Indianapolis, Ind. July 25, 2018 Anthem, Inc. (NYSE: ANTM) reported second quarter 2018 financial results driven by strong medical cost performance and a continued focus on optimizing
Read more →-ELV
May 10, 2018Chief Operating Officer Deepti Jain to Lead IngenioRx INDIANAPOLIS
Chief Operating Officer Deepti Jain to Lead IngenioRx INDIANAPOLIS May 10, 2018 Anthem, Inc. (NYSE:ANTM) announced today that Deepti Jain will lead IngenioRx, Anthem s newly launched pharmacy benefits manager (PBM). Ms. Jain, who is Chief Operating Officer of IngenioRx, has been
Read more →-ELV
Apr 25, 2018ANTHEM REPORTS FIRST QUARTER 2018 RESULTS REFLECTING STRONG MEDICAL COST PERFORMANCE First quarter net income increased 30% to $1.3 billion with margins improving across the company s business segments. Adj
ANTHEM REPORTS FIRST QUARTER 2018 RESULTS REFLECTING STRONG MEDICAL COST PERFORMANCE Indianapolis, Ind. April 25, 2018 Anthem, Inc. (NYSE: ANTM) reported strong first quarter 2018 financial results and improved margins while continuing to make strategic investments in growth in
Read more →-ELV
Jan 31, 2018ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS REFLECTING BALANCED PERFORMANCE ACROSS ITS BUSINESS UNITS Operating revenues grew 5.8% year-over-year to $89.1 billion. Medical enrollment increased
ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS REFLECTING BALANCED PERFORMANCE ACROSS ITS BUSINESS UNITS Indianapolis, Ind. January 31, 2018 Anthem, Inc. (NYSE: ANTM) today reported solid fourth quarter and full year 2017 financial results that reflected a continued f
Read more →-ELV
Dec 7, 2017Anthem s Board Welcomes Antonio Neri as New Director Indianapolis
Anthem s Board Welcomes Antonio Neri as New Director Indianapolis December 7, 2017 Anthem, Inc. (NYSE: ANTM) announced today that Antonio Neri has been named to its Board of Directors effective December 6, 2017. Mr. Neri brings more than 25 years of leadership experience and ex
Read more →-ELV
Nov 29, 2017Anthem Announces Results of Its Tender Offer for Notes due 2034, 2036, 2037, 2040 and 2044 and Upsizing of the Maximum Purchase Amount
Anthem Announces Results of Its Tender Offer for Notes due 2034, 2036, 2037, 2040 and 2044 and Upsizing of the Maximum Purchase Amount November 29, 2017 INDIANAPOLIS (BUSINESS WIRE) Anthem, Inc. ( Anthem ) announced today the results of its previously announced cash tender offe
Read more →-ELV
Nov 20, 2017Anthem Announces Pricing of its Tender Offer for Any and All of its 7.000% Notes due 2019 Indianapolis, Ind.
Anthem Announces Pricing of its Tender Offer for Any and All of its 7.000% Notes due 2019 Indianapolis, Ind., November 20, 2017 Anthem, Inc. ( Anthem ) announced today the pricing of its previously announced cash tender offer (the Any and All Notes Offer ) for any and all of its
Read more →-ELV
Nov 14, 2017Anthem Launches Cash Tender Offers for Certain Outstanding Debt Securities INDIANAPOLIS (BUSINESS WIRE)
Anthem Launches Cash Tender Offers for Certain Outstanding Debt Securities INDIANAPOLIS (BUSINESS WIRE) November 14, 2017 Anthem, Inc. ( Anthem or the Company ) announced today the commencement of cash tender offers for (i) any and all of its Any and All Notes (defined below) an
Read more →-ELV
Nov 6, 2017Anthem, Inc. Announces Key Management Changes Board Elects Gail K. Boudreaux Chief Executive Officer and President Joseph R. Swedish Will Continue as Executive Chairman, Anthem Board of Directors and Senior Advisor INDIA
Anthem, Inc. Announces Key Management Changes Board Elects Gail K. Boudreaux Chief Executive Officer and President Joseph R. Swedish Will Continue as Executive Chairman, Anthem Board of Directors and INDIANAPOLIS November 6, 2017 Anthem, Inc. (the Company ) (NYSE: ANTM) today
Read more →-ELV
Oct 25, 2017ANTHEM REPORTS THIRD QUARTER 2017 RESULTS Net income was $2.80 per share, including net positive adjustment items of $0.15 per share. Adjusted net income was $2.65 per share (refer to the GAAP reconciliatio
ANTHEM REPORTS THIRD QUARTER 2017 RESULTS Indianapolis, Ind. October 25, 2017 Anthem, Inc. (NYSE: ANTM) today announced that third quarter 2017 net income was $746.9 million, or $2.80 per share. These results included net positive adjustment items of $0.15 per share. Net income
Read more →-ELV
Jul 26, 2017ANTHEM REPORTS SECOND QUARTER 2017 RESULTS Net income was $3.16 per share, including net negative adjustment items of $0.21 per share. Adjusted net income was $3.37 per share (refer to the GAAP reconciliati
ANTHEM REPORTS SECOND QUARTER 2017 RESULTS Indianapolis, Ind. July 26, 2017 Anthem, Inc. (NYSE: ANTM) today announced that second quarter 2017 net income was $855.3 million, or $3.16 per share. These results included net negative adjustment items of $0.21 per share. Net income i
Read more →-ELV
May 12, 2017Anthem Comments on Decision of the Delaware Court of Chancery on Acquisition of Cigna; Terminates Merger Agreement INDIANAPOLIS
Acquisition of Cigna; Terminates Merger Agreement About Anthem, Inc. Anthem is working to transform health care with trusted and caring solutions. Our health plan companies deliver quality products and services that give their members access to the care they need. With over 74
Read more →-ELV
May 5, 2017Anthem Files Petition for a Writ of Certiorari with the U.S. Supreme Court Regarding Acquisition of Cigna INDIANAPOLIS
Anthem Files Petition for a Writ of Certiorari with the U.S. Supreme Court Regarding Acquisition of Cigna About Anthem, Inc. Anthem is working to transform health care with trusted and caring solutions. Our health plan companies deliver quality products and services that give
Read more →-ELV
Apr 28, 2017Anthem Responds to U.S. Court of Appeals Decision on Acquisition of Cigna INDIANAPOLIS
About Anthem, Inc. Anthem is working to transform health care with trusted and caring solutions. Our health plan companies deliver quality products and services that give their members access to the care they need. With over 74 million people served by its affiliated companies,
Read more →-ELV
Apr 26, 2017P R E S S R E L E A S E ANTHEM REPORTS FIRST QUARTER 2017 RESULTS Net income was $3.73 per share, including net negative adjustment items of $0.95 per share. Adjusted net income was $4.68 per share (refer to the GAAP rec
P R E S S R E L E A S E ANTHEM REPORTS FIRST QUARTER 2017 RESULTS Indianapolis, Ind. April 26, 2017 Anthem, Inc. (NYSE: ANTM) today announced that first quarter 2017 net income was $1,009.9 million, or $3.73 per share. These results included net negative adjustment items of $0.
Read more →-ELV
Feb 15, 2017Anthem Files Suit Against Cigna Seeking a Temporary Restraining Order to Enjoin Cigna from Terminating the Merger Agreement, Specific Performance Compelling Cigna to Comply with the Merger Agreement and Damages Anthem Ac
Anthem Files Suit Against Cigna Seeking a Temporary Restraining Order to Enjoin Cigna from Terminating the Merger Agreement, Specific Performance Compelling Cigna to Comply with the Merger Agreement and Damages Anthem Action is in Response to Cigna s Wrongful Purported Terminati
Read more →-ELV
Feb 9, 2017ANTHEM RESPONDS TO U.S. DISTRICT COURT S
About Anthem, Inc. Anthem is working to transform health care with trusted and caring solutions. Our health plan companies deliver quality products and services that give their members access to the care they need. With over 73 million people served by its affiliated companies,
Read more →-ELV
Feb 1, 2017P R E S S R E L E A S E ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2016 RESULTS Net income was $1.37 per share, including net negative adjustment items of $0.39 per share. Adjusted net income was $1.76 per share (refer
P R E S S R E L E A S E ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2016 RESULTS Indianapolis, Ind. February 1, 2017 Anthem, Inc. (NYSE: ANTM) today announced that fourth quarter 2016 net income was $368.4 million, or $1.37 per share. These results included net negative adjustm
Read more →-ELV
Nov 2, 2016P R E S S R E L E A S E ANTHEM REPORTS THIRD QUARTER 2016 RESULTS Net income was $2.30 per share, including net negative adjustment items of $0.15 per share. Adjusted net income was $2.45 per share (refer to the GAAP rec
P R E S S R E L E A S E ANTHEM REPORTS THIRD QUARTER 2016 RESULTS Indianapolis, Ind. November 2, 2016 Anthem, Inc. (NYSE: ANTM) today announced that third quarter 2016 net income was $617.8 million, or $2.30 per share. These results included net negative adjustment items of $0.
Read more →-ELV
Jul 27, 2016ANTHEM REPORTS SECOND QUARTER 2016 RESULTS Net income was $2.91 per share, including net negative adjustment items of $0.42 per share. Adjusted net income was $3.33 per share (refer to the GAAP reconciliation table on pa
ANTHEM REPORTS SECOND QUARTER 2016 RESULTS Indianapolis, Ind. July 27, 2016 Anthem, Inc. (NYSE: ANTM) today announced that second quarter 2016 net income was $780.6 million, or $2.91 per share. These results included net negative adjustment items of $0.42 per share. Net income i
Read more →-ELV
Jul 21, 2016Anthem Statement Regarding Action by the Department of Justice INDIANAPOLIS
Anthem Statement Regarding Action by the Department of Justice Investor Relations Douglas Simpson, 317-488-6181 Jill Becher, 414-234-1573 About Anthem, Inc. Anthem (NYSE: ANTM) is working to transform health care with trusted and caring solutions. Our health plan companies d
Read more →-ELV
May 4, 2016ANTHEM NAMES JOHN GALLINA CHIEF FINANCIAL OFFICER Wayne DeVeydt to Step Down Due to Family Commitments and Philanthropic Work INDIANAPOLIS , IN
ANTHEM NAMES JOHN GALLINA CHIEF FINANCIAL OFFICER Wayne DeVeydt to Step Down Due to Family Commitments and Philanthropic Work INDIANAPOLIS , IN May 4, 2016 Anthem, Inc. (NYSE: ANTM) announced today that John E. Gallina has been named Executive Vice President and Chief Financial
Read more →-ELV
Apr 27, 2016ANTHEM REPORTS FIRST QUARTER 2016 RESULTS Net income was $2.63 per share, including net negative adjustment items of $0.83 per share. Adjusted net income was $3.46 per share (refer to the GAAP reconciliation table on pag
ANTHEM REPORTS FIRST QUARTER 2016 RESULTS Indianapolis, Ind. April 27, 2016 Anthem, Inc. (NYSE: ANTM) today announced that first quarter 2016 net income was $703.0 million, or $2.63 per share. These results included net negative adjustment items of $0.83 per share. Net income in
Read more →-ELV
Mar 21, 2016Anthem files suit against pharmacy benefit manager to recover damages for pricing and operations issues INDIANAPOLIS
Anthem files suit against pharmacy benefit manager to recover damages for pricing and operations issues INDIANAPOLIS Mar. 21, 2016 Anthem, Inc. today filed suit against Express Scripts, its vendor for pharmacy benefit management services, to recover damages for pharmacy pricing
Read more →-ELV
Jan 27, 2016ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2015 RESULTS Net income was $0.68 per share, including net negative adjustment items of $0.46 per share. Adjusted net income was $1.14 per share (refer to the GAA
ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2015 RESULTS Indianapolis, Ind. January 27, 2016 Anthem, Inc. (NYSE: ANTM) today announced that fourth quarter 2015 net income was $180.9 million, or $0.68 per share. These results included net negative adjustment items of $0.46 per sh
Read more →-ELV
Dec 3, 2015P R E S S R E L E A S E ANTHEM ANNOUNCES SHAREHOLDER APPROVAL IN CONNECTION WITH CIGNA ACQUISITION Indianapolis, Ind.
ANTHEM ANNOUNCES SHAREHOLDER APPROVAL IN CONNECTION WITH CIGNA ACQUISITION Indianapolis, Ind. Dec. 3, 2015 Anthem, Inc. (NYSE: ANTM) announced that, during a special meeting held earlier today, Anthem shareholders voted to approve the issuance of Anthem common stock in the acqu
Read more →-ELV
Oct 28, 2015ANTHEM REPORTS THIRD QUARTER 2015 RESULTS Net income was $2.43 per share, including net negative adjustment items of $0.30 per share. Adjusted net income was $2.73 per share (refer to the GAAP reconciliation table on pag
ANTHEM REPORTS THIRD QUARTER 2015 RESULTS Indianapolis, Ind. October 28, 2015 Anthem, Inc. (NYSE: ANTM) today announced that third quarter 2015 net income was $654.8 million, or $2.43 per share. These results included net negative adjustment items of $0.30 per share. Net income
Read more →-ELV
Jul 29, 2015ANTHEM REPORTS SECOND QUARTER 2015 RESULTS Net income was $3.13 per share, including net gains of $0.03 per share. Adjusted net income was $3.10 per share (refer to the GAAP reconciliation table on page 14). Medical enro
ANTHEM REPORTS SECOND QUARTER 2015 RESULTS Indianapolis, Ind. July 29, 2015 Anthem, Inc. (NYSE: ANTM) today announced that second quarter 2015 net income was $859.1 million, or $3.13 per share. These results included net gains of $0.03 per share. Net income in the second quarter
Read more →-ELV
Jul 24, 2015Filed by Anthem, Inc. (Commission File No. 001-16751) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Cigna Corpor
Filed by Anthem, Inc. (Commission File No. 001-16751) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Subject Company: Cigna Corporation Commission File No. 001-08323 ANTHEM ANNOUNCES DEFINITIVE A
Read more →-ELV
Jun 22, 2015ANTHEM REITERATES COMMITMENT TO $184 PER SHARE PROPOSAL FOR CIGNA CORPORATION; SCHEDULES CALL TO PROVIDE UPDATE Combination would create a premier health benefits company with the critical diversification and scale to le
Filed by Anthem, Inc. (Commission File No. 001-16751) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Subject Company: Cigna Corporation Commission File No. 001-08323 ANTHEM REITERATES COMMITMENT
Read more →-ELV
May 26, 2015Anthem, Inc. Announces Retirement of Ken Goulet, Executive Vice President and President, Commercial and Specialty Business Division INDIANAPOLIS
Anthem, Inc. Announces Retirement of Ken Goulet, Executive Vice President and President, Commercial and Specialty Business Division INDIANAPOLIS May 26, 2015 Anthem, Inc. (NYSE: ANTM) today announced that Ken Goulet, Executive Vice President and President, Commercial and Special
Read more →-ELV
Apr 29, 2015ANTHEM REPORTS FIRST QUARTER 2015 RESULTS Net income was $3.09 per share, including net losses of $0.05 per share. Adjusted net income was $3.14 per share (refer to the GAAP reconciliation table on page 12). Medical enro
ANTHEM REPORTS FIRST QUARTER 2015 RESULTS Indianapolis, Ind. April 29, 2015 Anthem, Inc. (NYSE: ANTM) today announced that first quarter 2015 net income was $865.2 million, or $3.09 per share. These results included net losses of $0.05 per share. Net income in the first quarter
Read more →-ELV
Feb 18, 2015Anthem, Inc. Completes Acquisition of Simply Healthcare Holdings, Inc. INDIANAPOLIS
Anthem, Inc. Completes Acquisition of Simply Healthcare Holdings, Inc. INDIANAPOLIS February 18, 2015 Anthem, Inc. (NYSE: ANTM) announced today the completion of its acquisition of Simply Healthcare Holdings, Inc. ( Simply Healthcare ), a leading managed care company for people
Read more →-ELV
Jan 28, 2015ANTHEM REPORTS FOURTH QUARTER 2014 RESULTS Net income was $1.80 per share, including net gains of $0.07 per share. Adjusted net income was $1.73 per share (refer to the GAAP reconciliation table on page 15)
ANTHEM REPORTS FOURTH QUARTER 2014 RESULTS Indianapolis, Ind. January 28, 2015 Anthem, Inc. (NYSE: ANTM) today announced that fourth quarter 2014 net income was $506.7 million, or $1.80 per share. These results included net gains of approximately $0.07 per share. Net income in t
Read more →-ELV
Dec 22, 2014Anthem, Inc. to Acquire Simply Healthcare Holdings, Inc. Acquisition of Medicaid and Medicare Health Plans Advances Company s Business Growth Strategies INDIANAPOLIS
Anthem, Inc. to Acquire Simply Healthcare Holdings, Inc. Acquisition of Medicaid and Medicare Health Plans Advances Company s Business Growth Strategies INDIANAPOLIS December 22, 2014 Anthem, Inc. (NYSE: ANTM) announced today that it has entered into an agreement to acquire Sim
Read more →-ELV
Oct 29, 2014WELLPOINT REPORTS THIRD QUARTER 2014 RESULTS Net income was $2.22 per share, including net losses of $0.14 per share. Adjusted net income was $2.36 per share (refer to the GAAP reconciliation table on page
WELLPOINT REPORTS THIRD QUARTER 2014 RESULTS Indianapolis, Ind. October 29, 2014 WellPoint, Inc. (NYSE: WLP) today announced that third quarter 2014 net income was $630.9 million, or $2.22 per share. These results included net losses of approximately $0.14 per share. Net income
Read more →-ELV
Jul 30, 2014WELLPOINT REPORTS SECOND QUARTER 2014 RESULTS Net income was $2.56 per share, including net gains of $0.12 per share. Adjusted net income was $2.44 per share (refer to the GAAP reconciliation table on page
WELLPOINT REPORTS SECOND QUARTER 2014 RESULTS Indianapolis, Ind. July 30, 2014 WellPoint, Inc. (NYSE: WLP) today announced that second quarter 2014 net income was $731.1 million, or $2.56 per share. These results included net gains of approximately $0.12 per share. Net income in
Read more →-ELV
Apr 30, 2014WELLPOINT REPORTS FIRST QUARTER 2014 RESULTS Net income was $2.40 per share, including net gains of $0.10 per share. Adjusted net income was $2.30 per share (refer to the GAAP reconciliation table on page 12). Medical en
WELLPOINT REPORTS FIRST QUARTER 2014 RESULTS Indianapolis, Ind. April 30, 2014 WellPoint, Inc. (NYSE: WLP) today announced that first quarter 2014 net income was $701.0 million, or $2.40 per share. These results included net gains of approximately $0.10 per share. Net income in
Read more →-ELV
Apr 30, 2014WellPoint Announces Appointment of Thomas C. Zielinski as Executive Vice President and General Counsel, and Peter Haytaian as Executive Vice President and President of the Government Business Division INDIANAPOLIS
WellPoint Announces Appointment of Thomas C. Zielinski as Executive Vice President and General Counsel, and Peter Haytaian as Executive Vice President and President of the Government Business Division INDIANAPOLIS April 30, 2014 WellPoint, Inc. (NYSE: WLP) announced today that T
Read more →-ELV
Mar 21, 2014WELLPOINT RAISES 2014 FINANCIAL OUTLOOK Company now expects earnings per share to be greater than $8.20 in 2014, reflecting organic growth of 1.0 to 1.3 million new medical members Indianapolis, Ind.
WELLPOINT RAISES 2014 FINANCIAL OUTLOOK Company now expects earnings per share to be greater than $8.20 in 2014, reflecting organic growth of 1.0 to 1.3 million new medical members Indianapolis, Ind. March 21, 2014 WellPoint, Inc. (NYSE: WLP) today raised its full year 2014 ea
Read more →-ELV
Jan 29, 2014WELLPOINT REPORTS FOURTH QUARTER AND FULL YEAR 2013 RESULTS Fourth quarter net income was $0.49 per share, including costs of $0.38 per share from certain items. Adjusted net income was $0.87 per share (ref
WELLPOINT REPORTS FOURTH QUARTER AND FULL YEAR 2013 RESULTS Indianapolis, Ind. January 29, 2014 WellPoint, Inc. (NYSE: WLP) today announced that fourth quarter 2013 net income was $148.2 million, or $0.49 per share. These results included net costs of approximately $0.38 per sh
Read more →-ELV
Jan 7, 2014WellPoint Enters Agreement to Divest of 1-800 CONTACTS Subsidiary Indianapolis, IN
WellPoint Enters Agreement to Divest of 1-800 CONTACTS Subsidiary Indianapolis, IN January 7, 2014 WellPoint (NYSE: WLP) today announced it has signed a definitive agreement to sell its online contact lens retail subsidiary 1-800 CONTACTS to private equity firm Thomas H. Lee Par
Read more →-ELV
Oct 23, 2013WELLPOINT REPORTS THIRD QUARTER 2013 RESULTS Net income was $2.16 per share, including income of $0.06 per share from certain items. Adjusted net income was $2.10 per share (refer to page 14). Medical enrol
WELLPOINT REPORTS THIRD QUARTER 2013 RESULTS Indianapolis, Ind. October 23, 2013 WellPoint, Inc. (NYSE: WLP) today announced that third quarter 2013 net income was $656.2 million, or $2.16 per share. These results included net income of $0.06 per share, reflecting a favorable ta
Read more →-ELV
Sep 17, 2013WellPoint s Board Welcomes John Short and Elizabeth Tallett as New Directors Indianapolis, Ind.
WellPoint s Board Welcomes John Short and Elizabeth Tallett as New Directors Indianapolis, Ind. September 17, 2013 WellPoint, Inc. (NYSE: WLP) today announced that John Short and Elizabeth (Liz) Tallett, have been named to its Board of Directors, effective September 18, and Octo
Read more →Competitive Position
How ELV ranks across every disease it competes inCompetitive Position is a premium feature
See how ELV ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial